» Articles » PMID: 33159240

N-Methyl-D-aspartate Receptor Activation, Novel Mechanism of Homocysteine-induced Blood-retinal Barrier Dysfunction

Overview
Specialty General Medicine
Date 2020 Nov 7
PMID 33159240
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated levels of amino acid homocysteine (Hcy) recognized as hyperhomocysteinemia (HHcy) was reported in several human visual disorders, such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). Breakdown of blood-retinal barrier (BRB) is concomitant with vision loss in DR and AMD. We previously reported that HHcy alters BRB. Here, we tested the hypothesis that HHcy alters BRB via activation of N-methyl-D-aspartate receptor (NMDAR). Human retinal endothelial cells subjected to high level of Hcy and mouse model of HHcy were used. We injected Hcy intravitreal and used a mouse model of HHcy that lacks cystathionine-β-synthase (CBS). RT-PCR, western blot, and immunofluorescence showed that retinal endothelial cells (RECs) express NMDAR at the gene and protein levels both in vitro and in vivo and this was increased by HHcy. We assessed BRB function and retinal morphology using fluorescein angiogram and optical coherence tomography (OCT) under HHcy with and without pharmacological inhibition of NMDAR by (MK801) or in mice lacking endothelial NMDAR (NMDAR mouse). Additionally, retinal albumin leakage and tight junction proteins ZO-1 and occludin were assessed by western blotting analysis. Inhibition or elimination of NMDAR was able to improve the altered retinal hyperpermeability and morphology under HHcy as indicated by significant decrease in retinal albumin leakage and restoration of tight junction proteins ZO-1 and occludin. Our findings underscore a potential role for endothelial NMDAR in mediating Hcy-induced breakdown of BRB and subsequently as a potential therapeutic target in retinal diseases associated with HHcy such as DR and AMD. KEY MESSAGES: • Elevated levels of homocysteine (Hcy) are defined as hyperhomocysteinemia (HHcy). • HHcy is implicated in diabetic retinopathy and age-related macular degeneration. • HHcy alters BRB via activation of N-methyl-D-aspartate receptor.

Citing Articles

Zoledronate interrupts pre-osteoclast-induced angiogenesis via SDF-1/CXCR4 pathway.

Awad M, Taylor-Diaz E, Tawfik A, Hussein K, Elmansi A, Elashiry M Bone Rep. 2024; 23:101812.

PMID: 39583183 PMC: 11585646. DOI: 10.1016/j.bonr.2024.101812.


Exploring the role of Müller cells-derived exosomes in diabetic retinopathy.

Gad M, Elsherbiny N, El-Bassouny D, Omar N, Mahmoud S, Al-Shabrawey M Microvasc Res. 2024; 154:104695.

PMID: 38723843 PMC: 11180575. DOI: 10.1016/j.mvr.2024.104695.


Caffeic acid protects against l-methionine induced reduction in neurogenesis and cognitive impairment in a rat model.

Sirichoat A, Dornlakorn O, Saenno R, Aranarochana A, Sritawan N, Pannangrong W Heliyon. 2024; 10(5):e26919.

PMID: 38455532 PMC: 10918208. DOI: 10.1016/j.heliyon.2024.e26919.


Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma.

Anwar F, Al-Abbasi F, Naqvi S, Sheikh R, Alhayyani S, Asseri A Int J Nanomedicine. 2023; 18:2737-2756.

PMID: 37250469 PMC: 10211371. DOI: 10.2147/IJN.S405454.


Warburg Effect as a Novel Mechanism for Homocysteine-Induced Features of Age-Related Macular Degeneration.

Samra Y, Zaidi Y, Rajpurohit P, Raghavan R, Cai L, Kaddour-Djebbar I Int J Mol Sci. 2023; 24(2).

PMID: 36674587 PMC: 9865636. DOI: 10.3390/ijms24021071.


References
1.
Ibrahim A, Mander S, Hussein K, Elsherbiny N, Smith S, Al-Shabrawey M . Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration. Oncotarget. 2016; 7(8):8532-45. PMC: 4890985. DOI: 10.18632/oncotarget.7384. View

2.
Malaguarnera G, Gagliano C, Salomone S, Giordano M, Bucolo C, Pappalardo A . Folate status in type 2 diabetic patients with and without retinopathy. Clin Ophthalmol. 2015; 9:1437-42. PMC: 4536839. DOI: 10.2147/OPTH.S77538. View

3.
Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, MALINOW M . Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A. 1995; 92(5):1585-9. PMC: 42564. DOI: 10.1073/pnas.92.5.1585. View

4.
Liu X, Hunter C, Weiss H, Chi O . Effects of blockade of ionotropic glutamate receptors on blood-brain barrier disruption in focal cerebral ischemia. Neurol Sci. 2010; 31(6):699-703. DOI: 10.1007/s10072-010-0241-5. View

5.
Moore P, Roon P, Schoenlein P, Ganapathy V, Smith S . Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res. 2001; 73(1):45-57. DOI: 10.1006/exer.2001.1009. View